probenecid

1
Reactions 708 - 4 Jul 1998 Probenecid Hypersensitivity: case report A 48-year-old man with HIV infection developed a cutaneous hypersensitivity reaction to probenecid during treatment with a combination regimen of probenecid and cidofovir for a recurrence of peri-anal herpes simplex type 2 infection. Probenecid was given in combination with cidofovir in order to decrease the concentration of cidofovir in the urine, since cidofovir alone may cause renal toxicity. The patient tolerated 5 treatments of the cidofovir plus probenecid regimen, but his renal function then deteriorated, necessitating discontinuation of all his medications. However, 1 week later, the man mistakenly took probenecid 2g and developed generalised urticaria 1 hour later. His skin rash resolved 1 hour after he received diphenhydramine. Two weeks later, he accidentally ingested probenecid [dose not stated] again and developed the same skin reaction within 30 minutes. He was again treated with antihistamines and his symptoms resolved rapidly. Since the patient had initially had a good response to the cidofovir plus probenecid regimen, a second trial was initiated. He was premedicated with prednisone, cimetidine and diphenhydramine prior to probenecid treatment and was able to tolerate 3 further treatments with cidofovir plus probenecid. Author comment: ‘It appears that probenecid can be added to the growing list of medications associated with an increased incidence of adverse reactions in the AIDS population.’ Myers KW, et al. Probenecid hypersensitivity in AIDS: a case report. Annals of Allergy, Asthma and Immunology 80: 416-418, May 1998 - USA 800681659 1 Reactions 4 Jul 1998 No. 708 0114-9954/10/0708-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Upload: dangdien

Post on 16-Mar-2017

214 views

Category:

Documents


1 download

TRANSCRIPT

Reactions 708 - 4 Jul 1998

Probenecid

Hypersensitivity: case reportA 48-year-old man with HIV infection developed a

cutaneous hypersensitivity reaction to probenecid duringtreatment with a combination regimen of probenecid andcidofovir for a recurrence of peri-anal herpes simplex type 2infection. Probenecid was given in combination with cidofovirin order to decrease the concentration of cidofovir in the urine,since cidofovir alone may cause renal toxicity.

The patient tolerated 5 treatments of the cidofovir plusprobenecid regimen, but his renal function then deteriorated,necessitating discontinuation of all his medications. However,1 week later, the man mistakenly took probenecid 2g anddeveloped generalised urticaria 1 hour later. His skin rashresolved 1 hour after he received diphenhydramine. Twoweeks later, he accidentally ingested probenecid [dose notstated] again and developed the same skin reaction within 30minutes. He was again treated with antihistamines and hissymptoms resolved rapidly.

Since the patient had initially had a good response to thecidofovir plus probenecid regimen, a second trial was initiated.He was premedicated with prednisone, cimetidine anddiphenhydramine prior to probenecid treatment and was ableto tolerate 3 further treatments with cidofovir plus probenecid.

Author comment: ‘It appears that probenecid can be addedto the growing list of medications associated with an increasedincidence of adverse reactions in the AIDS population.’Myers KW, et al. Probenecid hypersensitivity in AIDS: a case report. Annals ofAllergy, Asthma and Immunology 80: 416-418, May 1998 - USA 800681659

1

Reactions 4 Jul 1998 No. 7080114-9954/10/0708-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved